The nociceptive and anti-nociceptive effects of bee venom injection and therapy: A double-edged sword

Progress in Neurobiology

Volumn 92, Issue 2, 2010, Pages 151-183

  Chen, Jun ^a,b   Lariviere, William R ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Anti nociception; Apitherapy; Bee venom; Central neural plasticity; Nociception; Pain signaling pathways; Peripheral neural plasticity

Indexed keywords

AMINO ACID; APAMIN; ASPARTIC ACID; BEE VENOM; ETOMIDATE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HYALURONIDASE; MAST CELL DEGRANULATING PEPTIDE; MELITTIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NOCICEPTIN; PHOSPHOLIPASE A2; PROPOFOL; PROSTAGLANDIN SYNTHASE; PROTEIN C FOS; PROTEIN KINASE; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; SEROTONIN; TACHYKININ RECEPTOR; VANILLOID RECEPTOR;

ALLODYNIA; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ELECTROPHYSIOLOGY; ENVENOMATION; EVALUATION; HUMAN; HYPERALGESIA; HYPERSENSITIVITY; NEUROCHEMISTRY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPINAL CORD DORSAL HORN; WITHDRAWAL REFLEX;

ANIMALS; BEE VENOMS; HUMANS; NOCICEPTORS; PAIN; PEPTIDES;

EID: 77954964702     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.06.006     Document Type: Review

References (436)

1. Abbott F.V., Franklin K.B., Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995, 60:91-102.
2. Abbott F.V., Ocvirk R., Najafee R., Franklin K.B. Improving the efficiency of the formalin test. Pain 1999, 83:561-569.
3. Adamek-Guzik T. Hypersensitivity to honey bee venom. Przegl Lek 1994, 51:161-166.
4. Aley K.O., McCarter G., Levine J.D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 1998, 18:7008-7014.
5. Aley K.O., Levine J.D. Role of protein kinase A in the maintenance of inflammatory pain. J. Neurosci. 1999, 19:2181-2186.
6. Allende D., Simon S.A., McIntosh T.J. Melittin-induced bilayer leakage depends on lipid material properties: evidence for toroidal pores. Biophys. J. 2005, 88:1828-1837.
7. Andrews K., Baranowski A., Kinnman E. Sensory threshold changes without initial pain or alterations in cutaneous blood flow, in the area of secondary hyperalgesia caused by topical application of capsaicin in humans. Neurosci. Lett. 1999, 266:45-48.
8. Annila I. Bee venom allergy. Clin. Exp. Allergy 2000, 30:1682-1687.
9. Armstrong D., Dry R.M., Keele C.A., Markham J.W. Method for studying chemical excitants of cutaneous pain in man. J. Physiol. 1951, 115:59-60.
10. Armstrong D., Dry R.M., Keele C.A., Markham J.W. Pain-producing substances in blister fluid and in serum. J. Physiol. 1952, 117:4p-5p.
11. Armstrong D., Dry R.M., Keele C.A., Markham J.W. Pain-producing actions of tryptamine and 5-hydroxytryptamine. J. Physiol. 1952, 117:70P-71P.
12. Armstrong D., Dry R.M., Keele C.A., Markham J.W. Observations on chemical excitants of cutaneous pain in man. J. Physiol. 1953, 120:326-351.
13. Armstrong D., Jepson J.B., Keele C.A., Stewart J.W. Activation by glass of pharmacologically active agents in blood of various species. J. Physiol. 1955, 129:80-81.
14. Armstrong D., Jepson J.B., Keele C.A., Stewart J.W. Pain-producing substance in human inflammatory exudates and plasma. J. Physiol. 1957, 135:350-370.
15. Armstrong D., Keele C.A., Jepson J.B., Stewart J.W. Development of pain-producing substance in human plasma. Nature 1954, 174:791-792.
16. Aukrust L., Einarsson R., Ohman S., Johansson S.G. Crossed radioimmunoelectrophoretic studies of bee venom allergens. Allergy 1982, 37:265-271.
17. Baek Y.H., Huh J.E., Lee J.D., Choi D.Y., Park D.S. Antinociceptive effect and the mechanism of bee venom acupuncture (Apipuncture) on inflammatory pain in the rat model of collagen-induced arthritis: mediation by alpha2-adrenoceptors. Brain Res. 2006, 1073-1074:305-310.
18. Banks B.E., Dempsey C.E., Vernon C.A., Warner J.A., Yamey J. Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo. Br. J. Pharmacol. 1990, 99:350-354.
19. Bardin L., Assie M.B., Pelissou M., Royer-Urios I., Newman-Tancredi A., Ribet J.P., Sautel F., Koek W., Colpaert F.C. Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-am ino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters. J. Pharmacol. Exp. Ther. 2005, 312:1034-1042.
20. Bardoni R., Goldstein P.A., Lee C.J., Gu J.G., MacDermott A.B. ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J. Neurosci. 1997, 17:5297-5304.
21. Barker S.A., Bayyuk S.H., Brimacombe J.S., Hawkins C.F., Stacey M. The structure of the hyaluronic acid component of synovial fluid in rheumatoid arthritis. Clin. Chim. Acta 1964, 9:339-343.
22. Barker S.A., Bayyuk S.I., Brimacombe J.S., Palmer D.J. Characterization of the products of the action of bee venom hyaluronidase. Nature 1963, 199:693-694.
23. Bar-Sela S., Levo Y. Bee venom immunotherapy: clinical and immunologic observations. Ann. Allergy 1981, 47:460-463.
24. Basbaum A.I. Spinal mechanisms of acute and persistent pain. Reg. Anesth. Pain Med. 1999, 24:59-67.
25. Baumann T.K., Simone D.A., Shain C.N., LaMotte R.H. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J. Neurophysiol. 1991, 66:212-227.
26. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J. Membr. Biol. 1997, 156:197-211.
27. Beck B.F. Bee Venom Therapy: Bee Venom, Its Nature, and Its Effect on Arthritic and Rheumatoid Conditions 1935, D. Appleton-Century Company Inc., New York/London.
28. Becucci L., Guidelli R. Kinetics of channel formation in bilayer lipid membranes (BLMs) and tethered BLMs: monazomycin and melittin. Langmuir 2007, 23:5601-5608.
29. Ben A.Y., Cherubini E., Aniksztejn L., Roisin M.P., Charriaut-Marlangue C. Mechanism of induction of long term potentiation by the mast cell degranulating peptide. Pharmacopsychiatry 1989, 22(Suppl. 2):107-110.
30. Bennett A. Anti-inflammatory drugs, cyclooxygenases and other factors. Exp. Opin. Pharmacother. 2001, 2:1-2.
31. Berman J. Imaging pain in humans. Br. J. Anaesth. 1995, 75:209-216.
32. Bernstein I.L., Li J.T., Bernstein D.I., Hamilton R., Spector S.L., Tan R., Sicherer S., Golden D.B., Khan D.A., Nicklas R.A., Portnoy J.M., Blessing-Moore J., Cox L., Lang D.M., Oppenheimer J., Randolph C.C., Schuller D.E., Tilles S.A., Wallace D.V., Levetin E., Weber R. Allergy diagnostic testing: an updated practice parameter. Ann. Allergy Asthma Immunol. 2008, 100:S1-S148.
33. Berthele A., Boxall S.J., Urban A., Anneser J.M., Zieglgansberger W., Urban L., Tolle T.R. Distribution and developmental changes in metabotropic glutamate receptor messenger RNA expression in the rat lumbar spinal cord. Brain Res. Dev. Brain Res. 1999, 112:39-53.
34. Bertolini A., Ottani A., Sandrini M. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem. 2002, 9:1033-1043.
35. Beschiaschvili G., Seelig J. Melittin binding to mixed phosphatidylglycerol/phosphatidylcholine membranes. Biochemistry-Us 1990, 29:52-58.
36. Bidard J.N., Gandolfo G., Mourre C., Gottesmann C., Lazdunski M. The brain response to the bee venom peptide MCD. Activation and desensitization of a hippocampal target. Brain Res. 1987, 418:235-244.
37. Bidard J.N., Mourre C., Gandolfo G., Schweitz H., Widmann C., Gottesmann C., Lazdunski M. Analogies and differences in the mode of action and properties of binding sites (localization and mutual interactions) of two K+ channel toxins. MCD peptide and dendrotoxin I. Brain Res. 1989, 495:45-57.
38. Bidard J.N., Mourre C., Lazdunski M. Two potent central convulsant peptides, a bee venom toxin, the MCD peptide, and a snake venom toxin, dendrotoxin I, known to block K+ channels, have interacting receptor sites. Biochem. Biophys. Res. Commun. 1987, 143:383-389.
39. Billingham M.E., Morley J., Hanson J.M., Shipolini R.A., Vernon C.A. Letter: an anti-inflammatory peptide from bee venom. Nature 1973, 245:163-164.
40. Bilo B.M., Bonifazi F. Advances in hymenoptera venom immunotherapy. Curr. Opin. Allergy Clin. Immunol. 2007, 7:567-573.
41. Bingel U., Schoell E., Buchel C. Imaging pain modulation in health and disease. Curr. Opin. Neurol. 2007, 20:424-431.
42. Birnbaumer L., Campbell K.P., Catterall W.A., Harpold M.M., Hofmann F., Horne W.A., Mori Y., Schwartz A., Snutch T.P., Tanabe T., et al. The naming of voltage-gated calcium channels. Neuron 1994, 13:505-506.
43. Blaauw P.J., Smithuis O.L., Elbers A.R. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy. J. Allergy Clin. Immunol. 1996, 98:39-47.
44. Blaser K., Carballido J., Faith A., Crameri R., Akdis C. Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Int. Arch. Allergy Immunol. 1998, 117:1-10.
45. Bleehen T., Hobbiger F., Keele C.A. Identification of algogenic substances in human erythrocytes. J. Physiol. 1976, 262:131-149.
46. Blumenthal R., Kempf C., Van Renswoude J., Weinstein J.N., Klausner R.D. Voltage-dependent orientation of membrane proteins. J. Cell Biochem. 1983, 22:55-67.
47. Boeynaems J.M., Communi D., Gonzalez N.S., Robaye B. Overview of the P2 receptors. Semin. Thromb. Hemost. 2005, 31:139-149.
48. Boland L.M., Allen A.C., Dingledine R. Inhibition by bradykinin of voltage-activated barium current in a rat dorsal root ganglion cell line: role of protein kinase C. J. Neurosci. 1991, 11:1140-1149.
49. Bonnot A., Corio M., Tramu G., Viala D. Immunocytochemical distribution of ionotropic glutamate receptor subunits in the spinal cord of the rabbit. J. Chem. Neuroanat. 1996, 11:267-278.
50. Bousquet J., Menardo J.L., Velasquez G., Michel F.B. Systemic reactions during maintenance immunotherapy with honey bee venom. Ann. Allergy 1988, 61:63-68.
51. Breithaupt H., Habermann E. MCD-peptide from bee venom: isolation, biochemical and pharmacological properties. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1968, 261:252-270.
52. Brown D.A. Acetylcholine. Br. J. Pharmacol. 2006, 147:S120-S126.
53. Burian M., Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol. Ther. 2005, 107:139-154.
54. Burnstock G. P2X receptors in sensory neurones. Br. J. Anaesth. 2000, 84:476-488.
55. Busse W.W., Reed C.E., Lichtenstein L.M., Reisman R.E. Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom. JAMA 1975, 231:1154-1156.
56. Calixto M.C., Triches K.M., Calixto J.B. Analysis of the inflammatory response in the rat paw caused by the venom of Apis melifera bee. Inflamm. Res. 2003, 52:132-139.
57. Calo' G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 2000, 129:1261-1283.
58. Cang C.L., Zhang H., Zhang Y.Q., Zhao Z.Q. PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons. Mol. Pain. 2009, 5:33.
59. Cao F.L., Liu M.G., Hao J., Li Z., Lu Z.M., Chen J. Different roles of spinal p38 and c-Jun N-terminal kinase pathways in bee venom-induced multiple pain-related behaviors. Neurosci. Lett. 2007, 427:50-54.
60. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313.
61. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
62. Caterina M.J., Julius D. Sense and specificity: a molecular identity for nociceptors. Curr. Opin. Neurobiol. 1999, 9:525-530.
63. Caterina M.J., Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 2001, 24:487-517.
64. Catterall W.A. Functional subunit structure of voltage-gated calcium channels. Science 1991, 253:1499-1500.
65. Catterall W.A., Perez-Reyes E., Snutch T.P., Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 2005, 57:411-425.
66. Catterall W.A., Striessnig J., Snutch T.P., Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 2003, 55:579-581.
67. Cervero F., Meyer R.A., Campbell J.N. A psychophysical study of secondary hyperalgesia: evidence for increased pain to input from nociceptors. Pain 1994, 58:21-28.
68. Cesare P., McNaughton P. Peripheral pain mechanisms. Curr. Opin. Neurobiol. 1997, 7:493-499.
69. Chang Y.H., Bliven M.L. Anti-arthritic effect of bee venom. Agents Actions 1979, 9:205-211.
70. Chaplan S.R. Neuropathic pain: role of voltage-dependent calcium channels. Reg. Anesth. Pain Med. 2000, 25:283-285.
71. Chaplan S.R., Pogrel J.W., Yaksh T.L. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 1994, 269:1117-1123.
72. Chen C.Y., Chen W.X., Sun X. Comparison of anti-inflammatory, analgesic activities, anaphylactogenicity and acute toxicity between bee venom and its peptides. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993, 13:226-227. 198.
73. Chen H.S., Chen J. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist. Eur. J. Pain 2000, 4:389-401.
74. Chen H.S., Chen J., Chen J., Guo W.G., Zheng M.H. Establishment of bee venom-induced contralateral heat hyperalgesia in the rat is dependent upon central temporal summation of afferent input from the site of injury. Neurosci. Lett. 2001, 298:57-60.
75. Chen H.S., Chen J., Sun Y.Y. Contralateral heat hyperalgesia induced by unilaterally intraplantar bee venom injection is produced by central changes: a behavioral study in the conscious rat. Neurosci. Lett. 2000, 284:45-48.
76. Chen H.S., He X., Qu F., Kang S.M., Yu Y., Liao D., Lu S.J. Differential roles of peripheral mitogen-activated protein kinase signal transduction pathways in bee venom-induced nociception and inflammation in conscious rats. J. Pain 2009, 10:201-207.
77. Chen H.S., He X., Wang Y., Wen W.W., You H.J., Arendt-Nielsen L. Roles of capsaicin-sensitive primary afferents in differential rat models of inflammatory pain: a systematic comparative study in conscious rats. Exp. Neurol. 2007, 204:244-251.
78. Chen H.S., Lei J., He X., Qu F., Wang Y., Wen W.W., You H.J., Arendt-Nielsen L. Peripheral involvement of PKA and PKC in subcutaneous bee venom-induced persistent nociception, mechanical hyperalgesia, and inflammation in rats. Pain 2008, 135:31-36.
79. Chen H.S., Lei J., He X., Wang Y., Wen W.W., Wei X.Z., Graven-Nielsen T., You H.J., Arendt-Nielsen L. Pivotal involvement of neurogenic mechanism in subcutaneous bee venom-induced inflammation and allodynia in unanesthetized conscious rats. Exp. Neurol. 2006, 200:386-391.
80. Chen H.S., Li M.M., Shi J., Chen J. Supraspinal contribution to development of both tonic nociception and referred mirror hyperalgesia: a comparative study between formalin test and bee venom test in the rat. Anesthesiology 2003, 98:1231-1236.
81. Chen J. The bee venom test: a novel useful animal model for study of spinal coding and processing of pathological pain information. Experimental Pathological Pain: From Molecules to Brain Functions 2003, 77-110. Science Press, Beijing. J. Chen, A.C.N. Chen, J. Han, W.D. Willis (Eds.).
82. Chen J. Processing of different 'phenotypes' of pain by different spinal signaling pathways. Cellular and Molecular Mechanisms for the Modulation of Nociceptive Transmission in the Peripheral and Central Nervous Systems 2007, 145-165. Research Signpost, Kerala, India. E. Kumamoto (Ed.).
83. Chen J. Spinal processing of bee venom-induced pain and hyperalgesia. Acta Physiol. Sinica 2008, 60:645-652.
84. Chen J., Chen H.S. Pivotal role of capsaicin-sensitive primary afferents in development of both heat and mechanical hyperalgesia induced by intraplantar bee venom injection. Pain 2001, 91:367-376.
85. Chen J., Koyama N. Differential activation of spinal dorsal horn units by subcutaneous formalin injection in the cat: an electrophysiological study. Exp. Brain Res. 1998, 118:14-18.
86. Chen J., Koyama N., Yokota T. Effects of subcutaneous formalin on responses of dorsal horn wide dynamic range neurons and primary afferent neurons in the cat. Pain Res. 1996, 11:71-83.
87. Chen J., Li H., Luo C., Li Z., Zheng J. Involvement of peripheral NMDA and non-NMDA receptors in development of persistent firing of spinal wide-dynamic-range neurons induced by subcutaneous bee venom injection in the cat. Brain Res. 1999, 844:98-105.
88. Chen J., Luo C., Li H., Chen H. Primary hyperalgesia to mechanical and heat stimuli following subcutaneous bee venom injection into the plantar surface of hindpaw in the conscious rat: a comparative study with the formalin test. Pain 1999, 83:67-76.
89. Chen J., Luo C., Li H.L. The contribution of spinal neuronal changes to development of prolonged, tonic nociceptive responses of the cat induced by subcutaneous bee venom injection. Eur. J. Pain 1998, 2:359-376.
90. Chen L.Y., Cheng C.W., Lin J.J., Chen W.Y. Exploring the effect of cholesterol in lipid bilayer membrane on the melittin penetration mechanism. Anal. Biochem. 2007, 367:49-55.
91. Chen L., Huang L.Y. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992, 356:521-523.
92. Chen X., Wang J., Kristalyn C.B., Chen Z. Real-time structural investigation of a lipid bilayer during its interaction with melittin using sum frequency generation vibrational spectroscopy. Biophys. J. 2007, 93:866-875.
93. Chen Y.N., Li K.C., Li Z., Shang G.W., Liu D.N., Lu Z.M., Zhang J.W., Ji Y.H., Gao G.D., Chen J. Effects of bee venom peptidergic components on rat pain-related behaviors and inflammation. Neuroscience 2006, 138:631-640.
94. Cherubini E., Ben A.Y., Gho M., Bidard J.N., Lazdunski M. Long-term potentiation of synaptic transmission in the hippocampus induced by a bee venom peptide. Nature 1987, 328:70-73.
95. Chizh B.A., Illes P. P2X receptors and nociception. Pharmacol. Rev. 2001, 53:553-568.
96. Clapp L.E., Klette K.L., DeCoster M.A., Bernton E., Petras J.M., Dave J.R., Laskosky M.S., Smallridge R.C., Tortella F.C. Phospholipase A2-induced neurotoxicity in vitro and in vivo in rats. Brain Res. 1995, 693:101-111.
97. Clinton P.M., Kemeny D.M., Youlten L.J., Lessof M.H. Histamine release from peripheral blood leukocytes with purified bee venom allergens: effect of hyperimmune beekeeper plasma. Int. Arch. Allergy Appl. Immunol. 1989, 89:43-48.
98. Coggeshall R.E. Fos, nociception and the dorsal horn. Prog. Neurobiol. 2005, 77:299-352.
99. Colpaert F.C., Deseure K., Stinus L., Adriaensen H. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J. Pharmacol. Exp. Ther. 2006, 316:892-899.
100. Cook D.B., Stegner A.J., McLoughlin M.J. Imaging pain of fibromyalgia. Curr. Pain Headache Rep. 2007, 11:190-200.
101. Cooper B., Bomalaski J.S. Activation of mechanonociceptors by pro-inflammatory peptides melittin and PLAP peptide. Exp. Brain Res. 1994, 100:18-28.
102. Cortright D.N., Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur. J. Biochem. 2004, 271:1814-1819.
103. Crabbe J.C., Phillips T.J., Kosobud A., Belknap J.K. Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin. Exp. Res. 1990, 14:141-151.
104. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001, 20:499-508.
105. Cuende E., Fraguas J., Pena J.E., Pena F., Garcia J.C., Gonzalez M. Beekeeper' arthropathy. J. Rheumatol. 1999, 26:2684-2690.
106. Cui X.Y., Dai Y., Wang S.L., Yamanaka H., Kobayashi K., Obata K., Chen J., Noguchi K. Differential activation of p38 and extracellular signal-regulated kinase in spinal cord in a model of bee venom-induced inflammation and hyperalgesia. Mol. Pain 2008, 4:17.
107. Devey M.E., Lee S.R., Richards D., Kemeny D.M. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy. J. Allergy Clin. Immunol. 1989, 84:326-330.
108. Dickenson A., Haley J., Schachter M., Chapman V. Electrophysiological approaches to the study of bradykinin and nitric oxide in inflammatory pain. Agents Actions Suppl. 1992, 38(Pt 2):358-365.
109. Dina O.A., Barletta J., Chen X., Mutero A., Martin A., Messing R.O., Levine J.D. Key role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the rat. J. Neurosci. 2000, 20:8614-8619.
110. Djouhri L., Bleazard L., Lawson S.N. Association of somatic action potential shape with sensory receptive properties in guinea-pig dorsal root ganglion neurones. J. Physiol. 1998, 513(Pt 3):857-872.
111. Dohrn C.S., Beitz A.J. NMDA receptor mRNA expression in NOS-containing neurons in the spinal trigeminal nucleus of the rat. Neurosci. Lett. 1994, 175:28-32.
112. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977, 4:161-174.
113. Dudkin S.M., Mikchaylova L.I., Severin E.S. Mechanisms of cyclic AMP phosphodiesterase regulation. Adv. Enzyme Regul. 1983, 21:333-352.
114. Dufourcq J., Faucon J.F., Fourche G., Dasseux J.L., Le M.M., Gulik-Krzywicki T. Morphological changes of phosphatidylcholine bilayers induced by melittin: vesicularization, fusion, discoidal particles. Biochim. Biophys. Acta 1986, 859:33-48.
115. Dunn J.D., Killion J.J. Melittin-evoked increase in plasma corticosterone levels. Life Sci. 1988, 43:335-343.
116. Edstrom A., Briggman M., Ekstrom P.A. Phospholipase A2 activity is required for regeneration of sensory axons in cultured adult sciatic nerves. J. Neurosci. Res. 1996, 43:183-189.
117. Eich-Wanger C., Muller U.R. Bee sting allergy in beekeepers. Clin. Exp. Allergy 1998, 28:1292-1298.
118. El K.M., Habermann E. Antibody formation by protein components of bee venom. Nature 1956, 178:1349.
119. Ertel E.A., Campbell K.P., Harpold M.M., Hofmann F., Mori Y., Perez-Reyes E., Schwartz A., Snutch T.P., Tanabe T., Birnbaumer L., Tsien R.W., Catterall W.A. Nomenclature of voltage-gated calcium channels. Neuron 2000, 25:533-535.
120. Fattal E., Nir S., Parente R.A., Szoka F.C. Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry-Us 1994, 33:6721-6731.
121. Felix J.P., Liu J., Schmalhofer W.A., Bailey T., Bednarek M.A., Kinkel S., Weinglass A.B., Kohler M., Kaczorowski G.J., Priest B.T., Garcia M.L. Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapin. Biochemistry-Us 2006, 45:10129-10139.
122. Ferrante A., Mocatta F., Goh D.H. Changes in IgG and IgE antibody levels to bee venom during immunotherapy. Int. Arch. Allergy Appl. Immunol. 1986, 81:284-287.
123. Ferreira J., Santos A.R., Calixto J.B. The role of systemic, spinal and supraspinal L-arginine-nitric oxide-cGMP pathway in thermal hyperalgesia caused by intrathecal injection of glutamate in mice. Neuropharmacology 1999, 38:835-842.
124. Field M.J., Cox P.J., Stott E., Melrose H., Offord J., Su T.Z., Bramwell S., Corradini L., England S., Winks J., Kinloch R.A., Hendrich J., Dolphin A.C., Webb T., Williams D. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17537-17542.
125. Franklin R., Baer H. Comparison of honeybee venoms and their components from various sources. J. Allergy Clin. Immunol. 1975, 55:285-298.
126. Fredholm B. Studies on a mast cell degranulating factor in bee venom. Biochem. Pharmacol. 1966, 15:2037-2043.
127. Frey S., Tamm L.K. Orientation of melittin in phospholipid bilayers. A polarized attenuated total reflection infrared study. Biophys. J. 1991, 60:922-930.
128. Fujimoto I., Ikenaka K., Kondo T., Aimoto S., Kuno M., Mikoshiba K. Mast cell degranulating (MCD) peptide and its optical isomer activate GTP binding protein in rat mast cells. Febs Lett. 1991, 287:15-18.
129. Gandolfo G., Gottesmann C., Bidard J.N., Lazdunski M. K+ channels openers prevent epilepsy induced by the bee venom peptide MCD. Eur. J. Pharmacol. 1989, 159:329-330.
130. Gauldie J., Hanson J.M., Rumjanek F.D., Shipolini R.A., Vernon C.A. The peptide components of bee venom. Eur. J. Biochem. 1976, 61:369-376.
131. Gauldie J., Hanson J.M., Shipolini R.A., Vernon C.A. The structures of some peptides from bee venom. Eur. J. Biochem. 1978, 83:405-410.
132. Goettl V.M., Larson A.A. Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Pain 1996, 67:435-441.
133. Golden D.B. Epidemiology of allergy to insect venoms and stings. Allergy Proc. 1989, 10:103-107.
134. Golden D.B. Insect sting allergy and venom immunotherapy. Ann. Allergy Asthma Immunol. 2006, 96:S16-S21.
135. Golden D.B., Kagey-Sobotka A., Norman P.S., Hamilton R.G., Lichtenstein L.M. Insect sting allergy with negative venom skin test responses. J. Allergy Clin. Immunol. 2001, 107:897-901.
136. Gu J.G., Bardoni R., Magherini P.C., MacDermott A.B. Effects of the P2-purinoceptor antagonists suramin and pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid on glutamatergic synaptic transmission in rat dorsal horn neurons of the spinal cord. Neurosci. Lett. 1998, 253:167-170.
137. Gu J.G., Heft M.W. P2X receptor-mediated purinergic sensory pathways to the spinal cord dorsal horn. Purinergic Signal. 2004, 1:11-16.
138. Gu J.G., MacDermott A.B. Activation of ATP P2X receptors elicits glutamate release from sensory neuron synapses. Nature 1997, 389:749-753.
139. Guo S.W., Liu M.G., Long Y.L., Ren L.Y., Lu Z.M., Yu H.Y., Hou J.F., Li H., Gao C.Y., Cui X.Y., An Y.Y., Li J., Zhao L.F., Chen J. Region- or state-related differences in expression and activation of extracellular signal-regulated kinases (ERKs) in naive and pain-experiencing rats. BMC Neurosci. 2007, 8:53.
140. Habermann E. Studies on the inhibition of blood coagulation by bee venom. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1954, 223:182-197.
141. Habermann E. Properties and concentration of hyaluronidase in bee venom. Biochem. Z. 1957, 329:1-10.
142. Habermann E. Chemistry, pharmacology, and toxicology of bee, wasp, and hornet venoms. Venomous Animals and Their Toxins. Volume III, Venomous Invertebrates 1971, 61-93. Academic Press, New York. W. Bucherl, E.E. Buckley (Eds.).
143. Habermann E. Bee and wasp venoms. Science 1972, 177:314-322.
144. Habermann E. Pharmacologically important substances in the bee- and wasp-venoms. Pharm. Unserer. Zeit. 1974, 3:145-151.
145. Habermann E., Breithaupt H. MCL-peptide, a selectively mastocytolytic factor isolated from bee venom. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1968, 260:127-128.
146. Habermann E., Reiz K.G. On the biochemistry of bee venom peptides, melittin and apamin. Biochem. Z. 1965, 343:192-203.
147. Habermehl G.G. Venomous Animals and Their Toxins 1981, Springer-Verlag, New York.
148. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992, 31:251-258.
149. Han S., Lee K., Yeo J., Kweon H., Woo S., Lee M., Baek H., Kim S., Park K. Effect of honey bee venom on microglial cells nitric oxide and tumor necrosis factor-alpha production stimulated by LPS. J. Ethnopharmacol. 2007, 111:176-181.
150. Hao J., Liu M.G., Yu Y.Q., Cao F.L., Li Z., Lu Z.M., Chen J. Roles of peripheral mitogen-activated protein kinases in melittin-induced nociception and hyperalgesia. Neuroscience 2008, 152:1067-1075.
151. Harper A.A., Lawson S.N. Electrical properties of rat dorsal root ganglion neurones with different peripheral nerve conduction velocities. J. Physiol. 1985, 359:47-63.
152. Harris J.A. Using c-fos as a neural marker of pain. Brain Res. Bull. 1998, 45:1-8.
153. Hartman D.A., Tomchek L.A., Lugay J.R., Lewin A.C., Chau T.T., Carlson R.P. Comparison of antiinflammatory and antiallergic drugs in the melittin- and D49 PLA2-induced mouse paw edema models. Agents Actions 1991, 34:84-88.
154. Harvey P., Sperber S., Kette F., Heddle R.J., Roberts-Thomson P.J. Bee-sting mortality in Australia. Med. J. Aust. 1984, 140:209-211.
155. Hassid A., Levine L. Stimulation of phospholipase activity and prostaglandin biosynthesis by melittin in cell culture and in vivo. Res. Commun. Chem. Pathol. Pharmacol. 1977, 18:507-517.
156. Hegmann J.P., Possidente B. Estimating genetic correlations from inbred strains. Behav. Genet. 1981, 11:103-114.
157. Hermetter A., Lakowicz J.R. The aggregation state of mellitin in lipid bilayers. An energy transfer study. J. Biol. Chem. 1986, 261:8243-8248.
158. Hider R.C., Ragnarsson U. A comparative structural study of apamin and related bee venom peptides. Biochim. Biophys. Acta 1981, 667:197-208.
159. Hoffman D.R., Shipman W.H., Babin D. Allergens in bee venom II. Two new high molecular weight allergenic specificities. J. Allergy Clin. Immunol. 1977, 59:147-153.
160. Hoffmann C. COX-2 in brain and spinal cord implications for therapeutic use. Curr. Med. Chem. 2000, 7:1113-1120.
161. Hoheisel U., Unger T., Mense S. The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neurones. Pain 2005, 117:358-367.
162. Hong S.J., Rim G.S., Yang H.I., Yin C.S., Koh H.G., Jang M.H., Kim C.J., Choe B.K., Chung J.H. Bee venom induces apoptosis through caspase-3 activation in synovial fibroblasts of patients with rheumatoid arthritis. Toxicon 2005, 46:39-45.
163. Hong Y., Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 1994, 63:827-836.
164. Hristova K., Dempsey C.E., White S.H. Structure, location, and lipid perturbations of melittin at the membrane interface. Biophys. J. 2001, 80:801-811.
165. Hu H., Chen D., Li Y., Zhang X. Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in vitro and Balb/c nude mice in vivo. J. Pharm. Pharmacol. 2006, 58:83-89.
166. Hu H., Chen D., Liu Y., Deng Y., Yang S., Qiao M., Zhao J., Zhao X. Target ability and therapy efficacy of immunoliposomes using a humanized antihepatoma disulfide-stabilized Fv fragment on tumor cells. J. Pharm. Sci. 2006, 95:192-199.
167. Hu H., Chen D., Liu Y., Deng Y., Yang S., Qiao M., Zhao J., Zhao X. Preparation and targeted delivery of immunoliposomes bearing poly(ethylene glycol)-coupled humanized anti-hepatoma disulfide-stabilized Fv (hdsFv25) in vitro. Pharmazie 2006, 61:685-688.
168. Hugues M., Romey G., Duval D., Vincent J.P., Lazdunski M. Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: voltage-clamp and biochemical characterization of the toxin receptor. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:1308-1312.
169. Hunt S.P., Pini A., Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328:632-634.
170. Ide T., Taguchi T., Morita T., Sato M., Ikenaka K., Aimoto S., Kondo T., Hojo H., Kasai M., Mikoshiba K. Mast cell degranulating peptide forms voltage gated and cation-selective channels in lipid bilayers. Biochem. Biophys. Res. Commun. 1989, 163:155-160.
171. Inoue K. Purinergic systems in microglia. Cell Mol. Life Sci. 2008, 65:3074-3080.
172. Jang H.S., Chung H.S., Ko E., Shin J.S., Shin M.K., Hong M.C., Kim Y., Min B.I., Bae H. Microarray analysis of gene expression profiles in response to treatment with bee venom in lipopolysaccharide activated RAW 264.7 cells. J. Ethnopharmacol. 2009, 121:213-220.
173. Jang H.S., Kim S.K., Han J.B., Ahn H.J., Bae H., Min B.I. Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line. J. Ethnopharmacol. 2005, 99:157-160.
174. Jang M.H., Shin M.C., Lim S., Han S.M., Park H.J., Shin I., Lee J.S., Kim K.A., Kim E.H., Kim C.J. Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299. J. Pharmacol. Sci. 2003, 91:95-104.
175. Jasani B., Kreil G., Mackler B.F., Stanworth D.R. Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells. Biochem. J. 1979, 181:623-632.
176. Jeong I., Kim B.S., Lee H., Lee K.M., Shim I., Kang S.K., Yin C.S., Hahm D.H. Prolonged analgesic effect of PLGA-encapsulated bee venom on formalin-induced pain in rats. Int. J. Pharm. 2009, 380:62-66.
177. Ji R.R. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr. Drug Targets Inflamm. Allergy 2004, 3:299-303.
178. Ji R.R. Mitogen-activated protein kinases as potential targets for pain killers. Curr. Opin. Investig. Drugs 2004, 5:71-75.
179. Ji R.R., Gereau R.T., Malcangio M., Strichartz G.R. MAP kinase and pain. Brain Res. Rev. 2009, 60:135-148.
180. Jin W., Lu Z. Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels. Biochemistry-Us 1999, 38:14286-14293.
181. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature 2001, 413:203-210.
182. Jutel M., Pichler W.J., Skrbic D., Urwyler A., Dahinden C., Muller U.R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J. Immunol. 1995, 154:4187-4194.
183. Kammerer R., Chvatchko Y., Kettner A., Dufour N., Corradin G., Spertini F. Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy. J. Allergy Clin. Immunol. 1997, 100:96-103.
184. Kang S.S., Pak S.C., Choi S.H. The effect of whole bee venom on arthritis. Am. J. Chin. Med. 2002, 30:73-80.
185. Kanjhan R., Coulson E.J., Adams D.J., Bellingham M.C. Tertiapin-Q blocks recombinant and native large conductance K+ channels in a use-dependent manner. J. Pharmacol. Exp. Ther. 2005, 314:1353-1361.
186. Kaufmann W.E., Andreasson K.I., Isakson P.C., Worley P.F. Cyclooxygenases and the central nervous system. Prostaglandins 1997, 54:601-624.
187. Kay A.B., Lessof M.H. Allergy. Conventional and alternative concepts. A report of the Royal College of Physicians Committee on Clinical Immunology and Allergy. Clin. Exp. Allergy 1992, 22(Suppl 3):1-44.
188. Keele C.A. Chemical causes of pain & itch. Proc. R Soc. Med. 1957, 50:477-484.
189. Keele C.A. The chemistry of pain production. Proc. R Soc. Med. 1967, 60:419-422.
190. Kemeny D.M., Dalton N., Lawrence A.J., Pearce F.L., Vernon C.A. The purification and characterisation of hyaluronidase from the venom of the honey bee, Apis mellifera. Eur. J. Biochem. 1984, 139:217-223.
191. Kemeny D.M., MacKenzie-Mills M., Harries M.G., Youlten L.J., Lessof M.H. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens. J. Allergy Clin. Immunol. 1983, 72:376-385.
192. Kempf C., Klausner R.D., Weinstein J.N., Van Renswoude J., Pincus M., Blumenthal R. Voltage-dependent trans-bilayer orientation of melittin. J. Biol. Chem. 1982, 257:2469-2476.
193. Kennedy C. P2X receptors: targets for novel analgesics?. Neuroscientist 2005, 11:345-356.
194. Kennedy C., Assis T.S., Currie A.J., Rowan E.G. Crossing the pain barrier: P2 receptors as targets for novel analgesics. J. Physiol. 2003, 553:683-694.
195. Kettner A., Hughes G.J., Frutiger S., Astori M., Roggero M., Spertini F., Corradin G. Api m 6: a new bee venom allergen. J. Allergy Clin. Immunol. 2001, 107:914-920.
196. Khawaja A.M., Rogers D.F. Tachykinins: receptor to effector. Int. J. Biochem. Cell Biol. 1996, 28:721-738.
197. Kim H.W., Kwon Y.B., Ham T.W., Roh D.H., Yoon S.Y., Lee H.J., Han H.J., Yang I.S., Beitz A.J., Lee J.H. Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord fos expression in rats. J. Vet. Med. Sci. 2003, 65:349-355.
198. Kim H.W., Kwon Y.B., Han H.J., Yang I.S., Beitz A.J., Lee J.H. Antinociceptive mechanisms associated with diluted bee venom acupuncture (apipuncture) in the rat formalin test: involvement of descending adrenergic and serotonergic pathways. Pharmacol. Res. 2005, 51:183-188.
199. Klocek G., Schulthess T., Shai Y., Seelig J. Thermodynamics of Melittin Binding to Lipid Bilayers 2009, Aggregation/Pore Formation. Biochemistry-Us.
200. Koburova K.L., Michailova S.G., Shkenderov S.V. Further investigation on the antiinflammatory properties of adolapin-bee venom polypeptide. Acta Physiol. Pharmacol. Bulg. 1985, 11:50-55.
201. Koburova K., Mikhailova S., Shkenderov S. Antipyretic effect of a polypeptide from bee venom-adolapin. Eksp. Med. Morfol. 1984, 23:143-148.
202. Koles L., Furst S., Illes P. Purine ionotropic (P2X) receptors. Curr. Pharm. Des. 2007, 13:2368-2384.
203. Koltzenburg M., Lundberg L.E., Torebjork H.E. Dynamic and static components of mechanical hyperalgesia in human hairy skin. Pain 1992, 51:207-219.
204. Kondo T., Ikenaka K., Fujimoto I., Aimoto S., Kato H., Ito K., Taguchi T., Morita T., Kasai M., Mikoshiba K. K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptide. Neurosci. Res. 1992, 13:207-216.
205. Kondo T., Ikenaka K., Kato H., Ito K., Aimoto S., Hojo H., Mikoshiba K. Long-term enhancement of synaptic transmission by synthetic mast cell degranulating peptide and its localization of binding sites in hippocampus. Neurosci. Res. 1990, 8:147-157.
206. Konno S., Golden D.B., Schroeder J., Hamilton R.G., Lichtenstein L.M., Huang S.K. Level of osteopontin is increased after bee venom immunotherapy. J. Allergy Clin. Immunol. 2005, 115:1317-1318.
207. Konno S., Golden D.B., Schroeder J., Hamilton R.G., Lichtenstein L.M., Huang S.K. Increased expression of osteopontin is associated with long-term bee venom immunotherapy. J. Allergy Clin. Immunol. 2005, 115:1063-1067.
208. Konno S., Hizawa N., Nishimura M., Huang S.K. Osteopontin: a potential biomarker for successful bee venom immunotherapy and a potential molecule for inhibiting IgE-mediated allergic responses. Allergol. Int. 2006, 55:355-359.
209. Koumanov K., Momchilova A., Wolf C. Bimodal regulatory effect of melittin and phospholipase A2-activating protein on human type II secretory phospholipase A2. Cell Biol. Int. 2003, 27:871-877.
210. Koyama N., Hirata K., Hori K., Dan K., Yokota T. Computer-assisted infrared thermographic study of axon reflex induced by intradermal melittin. Pain 2000, 84:133-139.
211. Koyama N., Hirata K., Hori K., Dan K., Yokota T. Biphasic vasomotor reflex responses of the hand skin following intradermal injection of melittin into the forearm skin. Eur. J. Pain. 2002, 6:447-453.
212. Kwon Y.B., Ham T.W., Kim H.W., Roh D.H., Yoon S.Y., Han H.J., Yang I.S., Kim K.W., Beitz A.J., Lee J.H. Water soluble fraction (<10kDa) from bee venom reduces visceral pain behavior through spinal alpha 2-adrenergic activity in mice. Pharmacol. Biochem. Behav. 2005, 80:181-187.
213. Kwon Y.B., Kang M.S., Han H.J., Beitz A.J., Lee J.H. Visceral antinociception produced by bee venom stimulation of the Zhongwan acupuncture point in mice: role of alpha(2) adrenoceptors. Neurosci. Lett. 2001, 308:133-137.
214. Kwon Y.B., Kang M.S., Kim H.W., Ham T.W., Yim Y.K., Jeong S.H., Park D.S., Choi D.Y., Han H.J., Beitz A.J., Lee J.H. Antinociceptive effects of bee venom acupuncture (apipuncture) in rodent animal models: a comparative study of acupoint versus non-acupoint stimulation. Acupunct. Electrother. Res. 2001, 26:59-68.
215. Kwon Y.B., Kim H.W., Ham T.W., Yoon S.Y., Roh D.H., Han H.J., Beitz A.J., Yang I.S., Lee J.H. The anti-inflammatory effect of bee venom stimulation in a mouse air pouch model is mediated by adrenal medullary activity. J. Neuroendocrinol. 2003, 15:93-96.
216. Kwon Y.B., Kim J.H., Yoon J.H., Lee J.D., Han H.J., Mar W.C., Beitz A.J., Lee J.H. The analgesic efficacy of bee venom acupuncture for knee osteoarthritis: a comparative study with needle acupuncture. Am. J. Chin. Med. 2001, 29:187-199.
217. Kwon Y.B., Lee H.J., Han H.J., Mar W.C., Kang S.K., Yoon O.B., Beitz A.J., Lee J.H. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002, 71:191-204.
218. Kwon Y.B., Lee J.D., Lee H.J., Han H.J., Mar W.C., Kang S.K., Beitz A.J., Lee J.H. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 2001, 90:271-280.
219. LaMotte R.H., Lundberg L.E., Torebjork H.E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J. Physiol. 1992, 448:749-764.
220. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.F. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J. Neurophysiol. 1991, 66:190-211.
221. Landucci E.C., Toyama M., Marangoni S., Oliveira B., Cirino G., Antunes E., de Nucci G. Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2. Toxicon 2000, 38:199-208.
222. Lariviere W.R., Chesler E.J., Li Z., Shang G.W., Chen Y.N., Yu Y.Q., Lu Z.M., Chang Y., Luo C., Li K.C., Chen J. Correlations between edema and the immediate and prolonged painful consequences of inflammation: therapeutic implications?. Sheng Li Xue Bao 2005, 57:278-288.
223. Lariviere W.R., Melzack R. The bee venom test: a new tonic-pain test. Pain 1996, 66:271-277.
224. Lariviere W.R., Melzack R. The bee venom test: comparisons with the formalin test with injection of different venoms. Pain 2000, 84:111-112.
225. Lariviere W.R., Wilson S.G., Laughlin T.M., Kokayeff A., West E.E., Adhikari S.M., Wan Y., Mogil J.S. Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity. Pain 2002, 97:75-86.
226. Lee J.D., Kim S.Y., Kim T.W., Lee S.H., Yang H.I., Lee D.I., Lee Y.H. Anti-inflammatory effect of bee venom on type II collagen-induced arthritis. Am. J. Chin. Med. 2004, 32:361-367.
227. Lee J.D., Park H.J., Chae Y., Lim S. An overview of bee venom acupuncture in the treatment of arthritis. Evid. Based Complement Alternat. Med. 2005, 2:79-84.
228. Lee J.H. Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord Fos expression in rats. J. Vet. Med. Sci. 2003, 65:349-355.
229. Lee J.H. Acupoint stimulation with dilute bee venom (apipuncture) alleviates thermal hyperalgesia in a rodent neuropathic pain model: involvement of spinal alpha 2-adrenoceptors. J. Pain 2004, 7:500-512.
230. Lee J.H., Kwon Y.B., Han H.J., Mar W.C., Lee H.J., Yang I.S., Beitz A.J., Kang S.K. Bee venom pretreatment has both an antinociceptive and anti-inflammatory effect on carrageenan-induced inflammation. J. Vet. Med. Sci. 2001, 63:251-259.
231. Lee J.Y., Kang S.S., Kim J.H., Bae C.S., Choi S.H. Inhibitory effect of whole bee venom in adjuvant-induced arthritis. In Vivo 2005, 19:801-805.
232. Lee K.G., Cho H.J., Bae Y.S., Park K.K., Choe J.Y., Chung I.K., Kim M., Yeo J.H., Park K.H., Lee Y.S., Kim C.H., Chang Y.C. Bee venom suppresses LPS-mediated NO/iNOS induction through inhibition of PKC-alpha expression. J. Ethnopharmacol. 2009, 123:15-21.
233. Lee M.S., Pittler M.H., Shin B.C., Kong J.C., Ernst E. Bee venom acupuncture for musculoskeletal pain: a review. J. Pain 2008, 9:289-297.
234. Leith J.L., Wilson A.W., Donaldson L.F., Lumb B.M. Cyclooxygenase-1-derived prostaglandins in the periaqueductal gray differentially control C- versus A-fiber-evoked spinal nociception. J. Neurosci. 2007, 27:11296-11305.
235. Levinsson A., Holmberg H., Broman J., Zhang M., Schouenborg J. Spinal sensorimotor transformation: relation between cutaneous somatotopy and a reflex network. J. Neurosci. 2002, 22:8170-8182.
236. Li C.L., Li H.L., Chen J. Effect of age on the expression of transient receptor potential vanilloid (TRPV1) in the spinal cord of normal rats and rats with peripheral inflammation. Chin. J. Neuroanat. 2004, 20:137-142.
237. Li H.L., Chen J., Luo C. Peripherally suppressive effects of ketamine on subcutaneous bee venom-induced prolonged, persistent firing of spinal wide-dynamic-range neurons in the cat. Chin. J. Neuroanat. 2000, 16:222-230.
238. Li K.C., Chen J. Differential roles of spinal protein kinases C and a in development of primary heat and mechanical hypersensitivity induced by subcutaneous bee venom chemical injury in the rat. Neurosignals 2003, 12:292-301.
239. Li K.C., Chen J. Altered pain-related behaviors and spinal neuronal responses produced by s.c. injection of melittin in rats. Neuroscience 2004, 126:753-762.
240. Li K.C., Zheng J.H., Chen J. Involvement of spinal protein kinase C in induction and maintenance of both persistent spontaneous flinching reflex and contralateral heat hyperalgesia induced by subcutaneous bee venom in the conscious rat. Neurosci. Lett. 2000, 285:103-106.
241. Li M.M., Yu Y.Q., Fu H., Xie F., Xu L.X., Chen J. Extracellular signal-regulated kinases mediate melittin-induced hypersensitivity of spinal neurons to chemical and thermal but not mechanical stimuli. Brain Res. Bull. 2008, 77:227-232.
242. Li P., Calejesan A.A., Zhuo M. ATP P2x receptors and sensory synaptic transmission between primary afferent fibers and spinal dorsal horn neurons in rats. J. Neurophysiol. 1998, 80:3356-3360.
243. Li S.Q., Xing Y.L., Chen W.N., Yue S.L., Li L., Li W.B. Activation of NMDA receptor is associated with up-regulation of COX-2 expression in the spinal dorsal horn during nociceptive inputs in rats. Neurochem. Res. 2009, 34:1451-1463.
244. Li Z., Chen J. Roles of spinal cyclooxygenases in the development of bee venom-induced persistent spontaneous pain, primary hyperalgesia and spinal c-Fos protein expression in the rat. Chin. J. Neuroanat. 2000, 17:151-156.
245. Li Z., Luo C., Sun Y.Y., Chen J. Effects of etomidate on local synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. Acta Physiol. Sinica 2004, 56:413-418.
246. Lin Q., Peng Y.B., Willis W.D. Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors. J. Pharmacol. Exp. Ther. 1996, 276:958-967.
247. Lin Q., Wu J., Willis W.D. Dorsal root reflexes and cutaneous neurogenic inflammation after intradermal injection of capsaicin in rats. J. Neurophysiol. 1999, 82:2602-2611.
248. Lin Q., Zou X., Willis W.D. Adelta and C primary afferents convey dorsal root reflexes after intradermal injection of capsaicin in rats. J. Neurophysiol. 2000, 84:2695-2698.
249. Lindstrom E., Ravnefjord A., Brusberg M., Hjorth S., Larsson H., Martinez V. The selective 5-hydroxytryptamine 1A antagonist, AZD7371 [3(R)-(N,N-dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carbo xamide (R,R)-tartrate monohydrate] (robalzotan tartrate monohydrate), inhibits visceral pain-related visceromotor, but not autonomic cardiovascular, responses to colorectal distension in rats. J. Pharmacol. Exp. Ther. 2009, 329:1048-1055.
250. Liu M.G., Zhang F.K., Guo S.W., Zhao L.F., An Y.Y., Cui X.Y., Chen J. Phosphorylation of c-Jun N-terminal kinase isoforms and their different roles in spinal cord dorsal horn and primary somatosensory cortex. Neurosci. Lett. 2007, 427:39-43.
251. Liu S.I., Cheng H.H., Huang C.J., Chang H.C., Chen W.C., Chen I.S., Hsu S.S., Chang H.T., Huang J.K., Chen J.S., Lu Y.C., Jan C.R. Melittin-induced [Ca2+]i increases and subsequent death in canine renal tubular cells. Hum. Exp. Toxicol. 2008, 27:417-424.
252. Liu S., Yu M., He Y., Xiao L., Wang F., Song C., Sun S., Ling C., Xu Z. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 2008, 47:1964-1973.
253. Liu X.Y., Wu S.X., Wang Y.Y., Wang W., Zhou L., Li Y.Q. Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain. Neurosci. Lett. 2005, 375:42-46.
254. Liu Z.Y., Zhuang D.B., Lunderberg T., Yu L.C. Involvement of 5-hydroxytryptamine(1A) receptors in the descending anti-nociceptive pathway from periaqueductal gray to the spinal dorsal horn in intact rats, rats with nerve injury and rats with inflammation. Neuroscience 2002, 112:399-407.
255. Lopez-Garcia J.A. Serotonergic modulation of spinal sensory circuits. Curr. Top. Med. Chem. 2006, 6:1987-1996.
256. Lowy P.H., Sarmiento L., Mitchell H.K. Polypeptides minimine and melittin from bee venom: effects on Drosophila. Arch. Biochem. Biophys. 1971, 145:338-343.
257. Lu Z.M., Xie F., Fu H., Liu M.G., Cao F.L., Hao J., Chen J. Roles of peripheral P2X and P2Y receptors in the development of melittin-induced nociception and hypersensitivity. Neurochem. Res. 2008, 33:2085-2091.
258. Lundquist A., Wessman P., Rennie A.R., Edwards K. Melittin-lipid interaction: a comparative study using liposomes, micelles and bilayer disks. Biochim. Biophys. Acta 2008, 1778:2210-2216.
259. Luo C., Chen J. Involvement of peripheral NMDA receptors in persistent nociception induced by subcutaneous bee venom injection: a behavioral study. Chin. J. Neuroanat. 2000, 16:15-20.
260. Luo C., Chen J., Li H.L., Li J.S. Spatial and temporal expression of c-Fos protein in the spinal cord of anesthetized rat induced by subcutaneous bee venom injection. Brain Res. 1998, 806:175-185.
261. Luo Z.D., Cizkova D. The role of nitric oxide in nociception. Curr. Rev. Pain 2000, 4:459-466.
262. Malmberg A.B. Protein kinase subtypes involved in injury-induced nociception. Prog. Brain Res. 2000, 129:51-59.
263. Malmberg A.B., Brandon E.P., Idzerda R.L., Liu H., McKnight G.S., Basbaum A.I. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J. Neurosci. 1997, 17:7462-7470.
264. Malmberg A.B., Chen C., Tonegawa S., Basbaum A.I. Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 1997, 278:279-283.
265. Martin W.J., Liu H., Wang H., Malmberg A.B., Basbaum A.I. Inflammation-induced up-regulation of protein kinase Cgamma immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing. Neuroscience 1999, 88:1267-1274.
266. Marsden C.A. Dopamine. Br. J. Pharmacol. 2006, 147:S136-144.
267. Matsuzaki K., Yoneyama S., Miyajima K. Pore formation and translocation of melittin. Biophys. J. 1997, 73:831-838.
268. Matthews E.A., Dickenson A.H. Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathy. Pain 2001, 92:235-246.
269. Mayer D.J., Mao J., Price D.D. The association of neuropathic pain, morphine tolerance and dependence, and the translocation of protein kinase C. NIDA Res. Monogr. 1995, 147:269-298.
270. McHugh S.M., Deighton J., Stewart A.G., Lachmann P.J., Ewan P.W. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin. Exp. Allergy 1995, 25:828-838.
271. McMahon S.B., Koltzenburg M. Wall and Melzack's Textbook of Pain 2006, Elsevier Churchill Livingstone, Printed in China.
272. Merskey H., Bogduk N. Classification of Chronic Pain 1994, IASP Press, Seattle.
273. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995, 377:532-535.
274. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 1999, 57:1-164.
275. Minton S.A. Venom Diseases 1974, Charles C. Thomas, Springfield.
276. Miroshnikov A.I., Boikov V.A., Snezhkova L.G., Severin S.E., Shvets V.I. Interaction of tertiapin, a neurotoxin from bee venom, with calmodulin. Bioorg. Khim. 1983, 9:26-32.
277. Mizumura K., Sugiura T., Katanosaka K., Banik R.K., Kozaki Y. Excitation and sensitization of nociceptors by bradykinin: what do we know?. Exp. Brain Res. 2009, 196:53-65.
278. Mogil J.S. Animal models of pain: progress and challenges. Nat. Rev. Neurosci. 2009, 10:283-294.
279. Mollay C., Kreil G. Enhancement of bee venom phospholipase A2 activity by melittin, direct lytic factor from cobra venom and polymyxin B. Febs Lett. 1974, 46:141-144.
280. Moon D.O., Park S.Y., Lee K.J., Heo M.S., Kim K.C., Kim M.O., Lee J.D., Choi Y.H., Kim G.Y. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int. Immunopharmacol. 2007, 7:1092-1101.
281. Mourre C., Bidard J.N., Lazdunski M. High affinity receptors for the bee venom MCD peptide. Quantitative autoradiographic localization at different stages of brain development and relationship with MCD neurotoxicity. Brain Res. 1988, 446:106-112.
282. Muller U.R. Recent developments and future strategies for immunotherapy of insect venom allergy. Curr. Opin. Allergy Clin. Immunol. 2003, 3:299-303.
283. Muller U., Lanner A., Schmid P., Bischof M., Dreborg S., Hoigne R. A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom. Int. Arch. Allergy Appl. Immunol. 1985, 77:201-203.
284. Muller U., Thurnheer U., Patrizzi R., Spiess J., Hoigne R. Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract. Allergy 1979, 34:369-378.
285. Nakatsuka T., Furue H., Yoshimura M., Gu J.G. Activation of central terminal vanilloid receptor-1 receptors and alpha beta-methylene-ATP-sensitive P2X receptors reveals a converged synaptic activity onto the deep dorsal horn neurons of the spinal cord. J. Neurosci. 2002, 22:1228-1237.
286. Nakatsuka T., Gu J.G. ATP P2X receptor-mediated enhancement of glutamate release and evoked EPSCs in dorsal horn neurons of the rat spinal cord. J. Neurosci. 2001, 21:6522-6531.
287. Nam K.W., Je K.H., Lee J.H., Han H.J., Lee H.J., Kang S.K., Mar W. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch. Pharm. Res. 2003, 26:383-388.
288. Neugebauer V., Vanegas H., Nebe J., Rumenapp P., Schaible H.G. Effects of N- and L-type calcium channel antagonists on the responses of nociceptive spinal cord neurons to mechanical stimulation of the normal and the inflamed knee joint. J. Neurophysiol. 1996, 76:3740-3749.
289. Neuman R., Ari Y.B., Cherubini E. Mast cell degranulating peptide increases the frequency of spontaneous miniature postsynaptic currents in CA3 rat hippocampal neurons. Eur. J. Neurosci. 1991, 3:523-530.
290. Neumann W., Habermann E. Characterization of the substances of the bee venom. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1954, 222:267-287.
291. Nishiya T. Interaction of melittin and phospholipase A2 with azobenzene-containing phospholipid. J. Biochem. 1991, 109:383-388.
292. Nishiya T., Chou H.L. The study of lipid-protein interactions: effect of melittin on phase transition of phosphatidylethanolamine and sensitivity of phospholipases to phase state. J. Biochem. 1991, 110:732-736.
293. North R.A. The P2X3 subunit: a molecular target in pain therapeutics. Curr. Opin. Investig. Drugs 2003, 4:833-840.
294. North R.A. P2X3 receptors and peripheral pain mechanisms. J. Physiol. 2004, 554:301-308.
295. Ohki S., Marcus E., Sukumaran D.K., Arnold K. Interaction of melittin with lipid membranes. Biochim. Biophys. Acta 1994, 1194:223-232.
296. Omote K., Kawamata M., Satoh O., Iwasaki H., Namiki A. Spinal antinociceptive action of an N-Type voltage-dependent calcium channel blocker and the synergistic interaction with morphine. Anesthesiology 1996, 84:636-643.
297. Orsolic N., Sver L., Verstovsek S., Terzic S., Basic I. Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon 2003, 41:861-870.
298. Ovcharov R., Shkenderov S., Mihailova S. Anti-inflammatory effects of apamin. Toxicon 1976, 14:441-447.
299. Ozawa S., Kamiya H., Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 1998, 54:581-618.
300. Park H.J., Lee S.H., Son D.J., Oh K.W., Kim K.H., Song H.S., Kim G.J., Oh G.T., Yoon D.Y., Hong J.T. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 2004, 50:3504-3515.
301. Parsons M.E., Ganellin C.R. Histamine and its receptors. Br. J. Pharmacol. 2006, 147:S127-135.
302. Pastorello E.A., Incorvaia C., Vassellatti D., Qualizza R., Codecasa L.R. IgG subclass antibody response to hymenoptera venom. N. Engl. Reg. Allergy Proc. 1987, 8:437-441.
303. Paull B.R., Yunginger J.W., Gleich G.J. Melittin: an allergen of honeybee venom. J. Allergy Clin. Immunol. 1977, 59:334-338.
304. Pelissier T., Pajot J., Dallel R. The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain 2002, 96:81-87.
305. Peng X.L., Gao X.L., Chen J., Huang X., Chen H.S. Effects of intravenous Injections Paederiae and Stauntonia on spontaneous pain, hyperalgesia and inflammation induced by cutaneous chemical tissue injury in the rat. Acta Physiol. Sinica 2003, 55:516-524.
306. Peng X., Gao X., Chen J., Huang X., Chen H. Evaluation of antinociceptive effects of Radix Angelicae Dahuricae on persistent nociception: comparative study between bee venom test and formalin test. Chin. J. Neuroanat. 2004, 20:48-54.
307. Peng X., Gao X., Chen J., Huang X. Comparative study on the antinociceptive effects of Radix Angelicae Dahuricae decoction and its lyophilized powder. Zhongguo Zhongxiyi Jiehe Zazhi 2004, 24:243-247.
308. Petersen-Zeitz K.R., Basbaum A.I. Second messengers, the substantia gelatinosa and injury-induced persistent pain. Pain Suppl. 1999, 6:S5-S12.
309. Petersson P., Waldenstrom A., Fahraeus C., Schouenborg J. Spontaneous muscle twitches during sleep guide spinal self-organization. Nature 2003, 424:72-75.
310. Procter M.J., Houghton A.K., Faber E.S., Chizh B.A., Ornstein P.L., Lodge D., Headley P.M. Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cord. Neuropharmacology 1998, 37:1287-1297.
311. Putz T., Ramoner R., Gander H., Rahm A., Bartsch G., Thurnher M. Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate. Cancer Immunol. Immunother. 2006, 55:1374-1383.
312. Qian Y., Chao D.S., Santillano D.R., Cornwell T.L., Nairn A.C., Greengard P., Lincoln T.M., Bredt D.S. cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons. J. Neurosci. 1996, 16:3130-3138.
313. Raghuraman H., Chattopadhyay A. Orientation and dynamics of melittin in membranes of varying composition utilizing NBD fluorescence. Biophys. J. 2007, 92:1271-1283.
314. Ramu Y., Xu Y., Lu Z. Engineered specific and high-affinity inhibitor for a subtype of inward-rectifier K+ channels. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:10774-10778.
315. Regoli D., Nantel F. Pharmacology of neurokinin receptors. Biopolymers 1991, 31:777-783.
316. Regoli D., Nguyen K., Calo G. Neurokinin receptors. Comparison of data from classical pharmacology, binding, and molecular biology. Ann. N.Y. Acad. Sci. 1997, 812:144-146.
317. Regoli D., Nguyen Q.T., Jukic D., Rouissi N. Functional characterization of neurokinin receptors with agonists and antagonists. Regul. Pept. 1993, 46:287-289.
318. Rehm H., Bidard J.N., Schweitz H., Lazdunski M. The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels. Biochemistry-Us 1988, 27:1827-1832.
319. Rehm H., Lazdunski M. Purification and subunit structure of a putative K+-channel protein identified by its binding properties for dendrotoxin I. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:4919-4923.
320. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995, 270:792-794.
321. Roche A.K., Cook M., Wilcox G.L., Kajander K.C. A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammation. Pain 1996, 66:331-341.
322. Roh D.H., Kim H.W., Yoon S.Y., Kang S.Y., Kwon Y.B., Cho K.H., Han H.J., Ryu Y.H., Choi S.M., Lee H.J., Beitz A.J., Lee J.H. Bee venom injection significantly reduces nociceptive behavior in the mouse formalin test via capsaicin-insensitive afferents. J. Pain 2006, 7:500-512.
323. Roh D.H., Kwon Y.B., Kim H.W., Ham T.W., Yoon S.Y., Kang S.Y., Han H.J., Lee H.J., Beitz A.J., Lee J.H. Acupoint stimulation with diluted bee venom (apipuncture) alleviates thermal hyperalgesia in a rodent neuropathic pain model: involvement of spinal alpha 2-adrenoceptors. J. Pain 2004, 5:297-303.
324. Routh V.H., Helke C.J. Tachykinin receptors in the spinal cord. Prog. Brain Res. 1995, 104:93-108.
325. Rouzer C.A., Marnett L.J. Cyclooxygenases: structural and functional insights. J. Lipid Res. 2009, 50(Suppl.):S29-S34.
326. Saddi G., Abbott F.V. The formalin test in the mouse: a parametric analysis of scoring properties. Pain 2000, 89:53-63.
327. Sakurada T., Katsumata K., Tan-No K., Sakurada S., Kisara K. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 1992, 31:1279-1285.
328. Sawynok J. Adenosine and ATP receptors. Handb. Exp. Pharmacol. 2007, 309-328.
329. Schmidt R.R., Betz H., Rehm H. Inhibition of beta-bungarotoxin binding to brain membranes by mast cell degranulating peptide, toxin I, and ethylene glycol bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid. Biochemistry-US 1988, 27:963-967.
330. Schoch P., Sargent D.F. Quantitative analysis of the binding of melittin to planar lipid bilayers allowing for the discrete-charge effect. Biochim. Biophys. Acta 1980, 602:234-247.
331. Schoepfer R., Monyer H., Sommer B., Wisden W., Sprengel R., Kuner T., Lomeli H., Herb A., Kohler M., Burnashev N. Molecular biology of glutamate receptors. Prog. Neurobiol. 1994, 42:353-357.
332. Schouenborg J. Learning in sensorimotor circuits. Curr. Opin. Neurobiol. 2004, 14:693-697.
333. Schouenborg J. Action-based sensory encoding in spinal sensorimotor circuits. Brain Res. Rev. 2008, 57:111-117.
334. Schouenborg J., Sjolund B.H. Activity evoked by A- and C-afferent fibers in rat dorsal horn neurons and its relation to a flexion reflex. J. Neurophysiol. 1983, 50:1108-1121.
335. Schumacher M.J., Schmidt J.O., Egen N.B., Dillon K.A. Biochemical variability of venoms from individual European and Africanized honeybees (Apis mellifera). J. Allergy Clin. Immunol. 1992, 90:59-65.
336. Schumacher M.J., Tveten M.S., Egen N.B. Rate and quantity of delivery of venom from honeybee stings. J. Allergy Clin. Immunol. 1994, 93:831-835.
337. Schwarz G., Zong R.T., Popescu T. Kinetics of melittin induced pore formation in the membrane of lipid vesicles. Biochim. Biophys. Acta 1992, 1110:97-104.
338. Schweinhardt P., Lee M., Tracey I. Imaging pain in patients: is it meaningful?. Curr. Opin. Neurol. 2006, 19:392-400.
339. Sequier J.M., Lazdunski M. Mast cell degranulating peptide induces the expression of the c-fos proto-oncogene in hippocampus. Eur. J. Pharmacol. 1990, 180:179-181.
340. Sharma S.V. Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells. Oncogene 1993, 8:939-947.
341. Shin H.K., Kim J.H. Melittin selectively activates capsaicin-sensitive primary afferent fibers. Neuroreport 2004, 15:1745-1749.
342. Shkenderov S., Koburova K. Adolapin-a newly isolated analgetic and anti-inflammatory polypeptide from bee venom. Toxicon 1982, 20:317-321.
343. Simons F.E., Frew A.J., Ansotegui I.J., Bochner B.S., Golden D.B., Finkelman F.D., Leung D.Y., Lotvall J., Marone G., Metcalfe D.D., Muller U., Rosenwasser L.J., Sampson H.A., Schwartz L.B., van Hage M., Walls A.F. Practical allergy (PRACTALL) report: risk assessment in anaphylaxis. Allergy 2008, 63:35-37.
344. Smith R., Separovic F., Milne T.J., Whittaker A., Bennett F.M., Cornell B.A., Makriyannis A. Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers. J. Mol. Biol. 1994, 241:456-466.
345. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000, 69:145-182.
346. Snutch T.P., Sutton K.G., Zamponi G.W. Voltage-dependent calcium channels-beyond dihydropyridine antagonists. Curr. Opin. Pharmacol. 2001, 1:11-16.
347. Son D.J., Lee J.W., Lee Y.H., Song H.S., Lee C.K., Hong J.T. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol. Ther. 2007, 115:246-270.
348. Sousa A.M., Prado W.A. The dual effect of a nitric oxide donor in nociception. Brain Res. 2001, 897:9-19.
349. Spoerri P.E., Jentsch J., Glees P. Apamin from bee venom: effects of the neurotoxin on cultures of the embryonic mouse cortex. Neurobiology 1973, 3:207-214.
350. Spoerri P.E., Jentsch J., Glees P. Apamin from bee venom. Effects of the neurotoxin on subcellular particles of neural cultures. Febs Lett. 1975, 53:143-147.
351. Strom R., Podo F., Crifo C., Zaccai G. Structural aspects of the binding of melittin to phospholipid bilayers, as a model for protein-lipid interactions in membranes. Adv. Exp. Med. Biol. 1982, 148:195-207.
352. Stucky C.L., Medler K.A., Molliver D.C. The P2Y agonist UTP activates cutaneous afferent fibers. Pain 2004, 109:36-44.
353. Stuhlmeier K.M. Apis mellifera venom and melittin block neither NF-kappa B-p50-DNA interactions nor the activation of NF-kappa B, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. J. Immunol. 2007, 179:655-664.
354. Suh S.J., Kim K.S., Kim M.J., Chang Y.C., Lee S.D., Kim M.S., Kwon D.Y., Kim C.H. Effects of bee venom on protease activities and free radical damages in synovial fluid from type II collagen-induced rheumatoid arthritis rats. Toxicol. In Vitro 2006, 20:1465-1471.
355. Suh Y.G., Oh U. Activation and activators of TRPV1 and their pharmaceutical implication. Curr. Pharm. Des. 2005, 11:2687-2698.
356. Sumikura H., Andersen O.K., Drewes A.M., Arendt-Nielsen L. A comparison of hyperalgesia and neurogenic inflammation induced by melittin and capsaicin in humans. Neurosci. Lett. 2003, 337:147-150.
357. Sumikura H., Andersen O.K., Drewes A.M., Arendt-Nielsen L. Secondary heat hyperalgesia induced by melittin in humans. Eur. J. Pain 2006, 10:121-125.
358. Sun G.Y., Xu J., Jensen M.D., Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 2004, 45:205-213.
359. Sun Y.Y., Chen J., Xiong L., Li H., Zeng X. Suppressive effects of intrathecal etomidate on persistent pain induced by intraplantar bee venom injection in the conscious rat. J. Fourth Mil. Med. Univ. 1999, 20:300-303.
360. Sun Y.Y., Chen J., Xiong L., Li H., Zeng X. Effects of intravenous and intrathecal etomidate on thermal and mechanical hyperalgesia induced by intraplantar injection of bee venom in rats. Chin. J. Anesthesiol. 2001, 21:302-305.
361. Sun Y.Y., Li K.C., Chen J. Evidence for peripherally antinociceptive action of propofol in rats: behavioral and spinal neuronal responses to subcutaneous bee venom. Brain Res. 2005, 1043:231-235.
362. Sun Y.Y., Luo C., Li Z., Chen J. Differential actions of intrathecal nociceptin on persistent spontaneous nociception, hyperalgesia and inflammation produced by subcutaneous bee venom injection in conscious rats. Acta Physiol. Sinica 2004, 56:321-327.
363. Szekely J.I., Torok K., Mate G. The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites. Curr. Pharm. Des. 2002, 8:887-912.
364. Takahashi T., Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature 1993, 366:156-158.
365. Talbot J.C., Bernard E., Maurel J.P., Faucon J.F., Dufourcq J. Melittin-phospholipid interactions: binding of the mono- and tetrameric form of this peptide, and perturbations of the thermotropic properties of bilayers. Toxicon 1982, 20:199-202.
366. Talbot J.C., Faucon J.F., Dufourcq J. Different states of self-association of melittin in phospholipid bilayers. A resonance energy transfer approach. Eur. Biophys. J. 1987, 15:147-157.
367. Tao Y.X., Johns R.A. Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw. Neuroscience 2002, 112:439-446.
368. Taylor J.W., Bidard J.N., Lazdunski M. The characterization of high-affinity binding sites in rat brain for the mast cell-degranulating peptide from bee venom using the purified monoiodinated peptide. J. Biol. Chem. 1984, 259:13957-13967.
369. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543.
370. Torebjork H.E., Lundberg L.E., LaMotte R.H. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J. Physiol. 1992, 448:765-780.
371. Tosteson M.T., Alvarez O., Hubbell W., Bieganski R.M., Attenbach C., Caporales L.H., Levy J.J., Nutt R.F., Rosenblatt M., Tosteson D.C. Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channels. Biophys. J. 1990, 58:1367-1375.
372. Tosteson M.T., Tosteson D.C. The sting. Melittin forms channels in lipid bilayers. Biophys. J. 1981, 36:109-116.
373. Tracey I. Imaging pain. Br. J. Anaesth. 2008, 101:32-39.
374. Treede R.D., Cole J.D. Dissociated secondary hyperalgesia in a subject with a large-fibre sensory neuropathy. Pain 1993, 53:169-174.
375. Tsuda M., Koizumi S., Kita A., Shigemoto Y., Ueno S., Inoue K. Mechanical allodynia caused by intraplantar injection of P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor signaling in capsaicin-insensitive primary afferent neurons. J. Neurosci. 2000, 20:C90.
376. Tu A.T. Venoms: Chemistry and Molecular Biology 1977, John Wiley, Toronto.
377. Urban M.O., Gebhart G.F. Supraspinal contributions to hype.T.ralgesia. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7687-7692.
378. Urbanek R., Kemeny D.M., Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin. Allergy 1986, 16:317-322.
379. van den Bogaart G., Mika J.T., Krasnikov V., Poolman B. The lipid dependence of melittin action investigated by dual-color fluorescence burst analysis. Biophys. J. 2007, 93:154-163.
380. van der Staay F.J., Fanelli R.J., Blokland A., Schmidt B.H. Behavioral effects of apamin, a selective inhibitor of the SK(Ca)-channel, in mice and rats. Neurosci. Biobehav. Rev. 1999, 23:1087-1110.
381. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 1998, 38:97-120.
382. Vanegas H., Schaible H.G. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog. Neurobiol. 2001, 64:327-363.
383. Vanegas H., Schaible H. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 2000, 85:9-18.
384. Vernon L.P., Bell J.D. Membrane structure, toxins and phospholipase A2 activity. Pharmacol. Ther. 1992, 54:269-295.
385. Vetter G., Geisslinger G., Tegeder I. Release of glutamate, nitric oxide and prostaglandin E2 and metabolic activity in the spinal cord of rats following peripheral nociceptive stimulation. Pain 2001, 92:213-218.
386. Vick J.A., Mehlman B., Brooks R., Phillips S.J., Shipman W. Effect of the bee venom and melittin on plasma cortisol in the unanesthetized monkey. Toxicon 1972, 10:581-586.
387. Vick J.A., Shipman W.H., Brooks R. Beta adrenergic and anti-arrhythmic effects of cardiopep, a newly isolated substance from whole bee venom. Toxicon 1974, 12:139-144.
388. Vick J.A., Shipman W.H. Effects of whole bee venom and its fractions (apamin and melittin) on plasma cortisol levels in the dog. Toxicon 1972, 10:377-380.
389. Vogel H. Incorporation of melittin into phosphatidylcholine bilayers. Study of binding and conformational changes. FEBS Lett. 1981, 134:37-42.
390. Vogel H., Jahnig F., Hoffmann V., Stumpel J. The orientation of melittin in lipid membranes. A polarized infrared spectroscopy study. Biochim. Biophys. Acta 1983, 733:201-209.
391. Wadsworth J.D., Doorty K.B., Strong P.N. Comparable 30-kDa apamin binding polypeptides may fulfill equivalent roles within putative subtypes of small conductance Ca(2+)-activated K+ channels. J. Biol. Chem. 1994, 269:18053-18061.
392. Waldron J.B., Sawynok J. Peripheral P2X receptors and nociception: interactions with biogenic amine systems. Pain 2004, 110:79-89.
393. Wang L., Wang G., Sun Y., Zhang Y., Chen J. Inhibition of bee venom induced persistent pain by intrathecal propofol in rats. Chin. J. Anesthesiol. 2003, 23:118-119.
394. Wang W., Wu S.X., Wang Y.Y., Liu X.Y., Li Y.Q. 5-hydroxytryptamine1A receptor is involved in the bee venom induced inflammatory pain. Pain 2003, 106:135-142.
395. Wessman P., Stromstedt A.A., Malmsten M., Edwards K. Melittin-lipid bilayer interactions and the role of cholesterol. Biophys. J. 2008, 95:4324-4336.
396. Wheeler-Aceto H., Porreca F., Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 1990, 40:229-238.
397. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 1999, 79:143-180.
398. Williams J.C., Bell R.M. Membrane matrix disruption by melittin. Biochim. Biophys. Acta 1972, 288:255-262.
399. Willis W.D. Central plastic responses to pain. Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management 1994, vol. 2:301-324. IASP Press, Seattle.
400. Willis W.D. Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp. Brain Res. 1999, 124:395-421.
401. Willis W.D., Coggeshall R.E. Sensory Mechanisms of the Spinal Cord: Primary Afferent Neurons and the Spinal Dorsal Horn 2004, Kluwer Academic/Plenum Publishers, New York.
402. Winther L., Arnved J., Malling H.J., Nolte H., Mosbech H. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study. Clin. Exp. Allergy 2006, 36:254-260.
403. Wirkner K., Sperlagh B., Illes P. P2X3 receptor involvement in pain states. Mol. Neurobiol. 2007, 36:165-183.
404. Won C.H., Choi E.S., Hong S.S. Efficacy of bee venom injection for osteoarthritis patients. J. Korean Rheum. Assoc. 1999, 6:218-226. [in Korean].
405. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765-1769.
406. Wu S.X., Wang W., Wang Y.Y., Ni T.S., Li Y.Q., Yew D.T. C-fos antisense oligodeoxynucleotide decreases subcutaneous bee venom injection-induced nociceptive behavior and fos expression in the rat. Neurosignals 2002, 11:224-230.
407. Xu X., Grass S., Hao J., Xu I.S., Wiesenfeld-Hallin Z. Nociceptin/orphanin FQ in spinal nociceptive mechanisms under normal and pathological conditions. Peptides 2000, 21:1031-1036.
408. Xu X., Maggi C.A., Wiesenfeld-Hallin Z. On the role of NK-2 tachykinin receptors in the mediation of spinal reflex excitability in the rat. Neuroscience 1991, 44:483-490.
409. Xu X., Nelson J.W. Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry. Proteins 1993, 17:124-137.
410. Yajima Y., Narita M., Shimamura M., Narita M., Kubota C., Suzuki T. Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice. Brain Res. 2003, 992:288-293.
411. Yan L.H., Hou J.F., Liu M.G., Li M.M., Cui X.Y., Lu Z.M., Zhang F.K., An Y.Y., Shi L., Chen J. Imbalance between excitatory and inhibitory amino acids at spinal level is associated with maintenance of persistent pain-related behaviors. Pharmacol. Res. 2009, 59:290-299.
412. Ye Z., Westlund K.N. Ultrastructural localization of glutamate receptor subunits (NMDAR1, AMPA GluR1 and GluR2/3) and spinothalamic tract cells. Neuroreport 1996, 7:2581-2585.
413. Yiangou M., Konidaris C., Victoratos P., Hadjipetrou-Kourounakis L. Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development. Clin. Exp. Immunol. 1993, 94:156-162.
414. Yin C.S., Lee H.J., Hong S.J., Chung J.H., Koh H.G. Microarray analysis of gene expression in chondrosarcoma cells treated with bee venom. Toxicon 2005, 45:81-91.
415. Yoon S.Y., Kim H.W., Roh D.H., Kwon Y.B., Jeong T.O., Han H.J., Lee H.J., Choi S.M., Ryu Y.H., Beitz A.J., Lee J.H. The anti-inflammatory effect of peripheral bee venom stimulation is mediated by central muscarinic type 2 receptors and activation of sympathetic preganglionic neurons. Brain Res. 2005, 1049:210-216.
416. You H., Chen J. Differential effects of subcutaneous injection of formalin and bee venom on responses of wide-dynamic-range neurons in spinal dorsal horn of the rat. Eur. J. Pain 1999, 3:177-180.
417. You H.J., Chen J., Morch C.D., Arendt-Nielsen L. Differential effect of peripheral glutamate (NMDA, non-NMDA) receptor antagonists on bee venom-induced spontaneous nociception and sensitization. Brain Res. Bull. 2002, 58:561-567.
418. You H.J., Colpaert F.C., Arendt-Nielsen L. The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes. Exp. Neurol. 2005, 191:174-183.
419. You H.J., Colpaert F.C., Arendt-Nielsen L. Long-lasting descending and transitory short-term spinal controls on deep spinal dorsal horn nociceptive-specific neurons in response to persistent nociception. Brain Res. Bull. 2008, 75:34-41.
420. You H.J., Dahl M.C., Chen J., Arendt-Nielsen L. Simultaneous recordings of wind-up of paired spinal dorsal horn nociceptive neuron and nociceptive flexion reflex in rats. Brain Res. 2003, 960:235-245.
421. You H.J., Morch C.D., Chen J., Arendt-Nielsen L. Role of central NMDA versus non-NMDA receptor in spinal withdrawal reflex in spinal anesthetized rats under normal and hyperexcitable conditions. Brain Res. 2003, 981:12-22.
422. You H.J., Arendt-Nielsen L. Unilateral subcutaneous bee venom but not formalin injection causes contralateral hypersensitized wind-up and after-discharge of the spinal withdrawal reflex in anesthetized spinal rats. Exp. Neurol. 2005, 195:148-160.
423. Youlten L.J., Atkinson B.A., Lee T.H. The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp venom allergy. Clin. Exp. Allergy 1995, 25:159-165.
424. Yu H.Y., Liu M.G., Liu D.N., Shang G.W., Wang Y., Qi C., Zhang K.P., Song Z.J., Chen J. Antinociceptive effects of systemic paeoniflorin on bee venom-induced various 'phenotypes' of nociception and hypersensitivity. Pharmacol. Biochem. Behav. 2007, 88:131-140.
425. Yu Y.Q., Chen J. Activation of spinal extracellular signaling-regulated kinases by intraplantar melittin injection. Neurosci. Lett. 2005, 381:194-198.
426. Yu Y.Q., Zhao F., Chen J. Activation of ERK1/2 in the primary injury site is required to maintain melittin-enhanced wind-up of rat spinal wide-dynamic-range neurons. Neurosci. Lett. 2009, 459:137-141.
427. Yue H.Y., Fujita T., Kumamoto E. Phospholipase A2 activation by melittin enhances spontaneous glutamatergic excitatory transmission in rat substantia gelatinosa neurons. Neuroscience 2005, 135:485-495.
428. Zhang H., Cang C.L., Kawasaki Y., Liang L.L., Zhang Y.Q., Ji R.R., Zhao Z.Q. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: a novel pathway for heat hyperalgesia. J. Neurosci. 2007, 27:12067-12077.
429. Zhang X.C., Zhang Y.Q., Zhao Z.Q. Involvement of nitric oxide in long-term potentiation of spinal nociceptive responses in rats. Neuroreport 2005, 16:1197-1201.
430. Zhang Y., Yang Z., Gao X., Wu G. The role of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats. Pain 2001, 92:201-211.
431. Zheng J.H., Chen J. Modulatory roles of the adenosine triphosphate P2x-purinoceptor in generation of the persistent nociception induced by subcutaneous bee venom injection in the conscious rat. Neurosci. Lett. 2000, 278:41-44.
432. Zheng J.H., Chen J. Differential roles of spinal neurokinin 1/2 receptors in development of persistent spontaneous nociception and hyperalgesia induced by subcutaneous bee venom injection in the conscious rat. Neuropeptides 2001, 35:32-44.
433. Zheng J.H., Chen J., Arendt-Nielsen L. Complexity of tissue injury-induced nociceptive discharge of dorsal horn wide dynamic range neurons in the rat, correlation with the effect of systemic morphine. Brain Res. 2004, 1001:143-149.
434. Zheng J.H., Feng W., Jian Z., Chen J. Age-related changes in deterministic behaviors of nociceptive firing of rat dorsal horn neurons. Acta Physiol. Sinica 2004, 56:178-182.
435. Zheng J.H., Jian Z., Chen J. Detection of deterministic behavior within the tissue injury-induced persistent firing of nociceptive neurons in the dorsal horn of the rat spinal cord. J. Comput. Neurosci. 2002, 13:23-34.
436. Zhuo M., Meller S.T., Gebhart G.F. Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain 1993, 54:71-78.